Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: E. Charters who wrote (81221)	1/28/2002 6:47:03 PM
From: long-gone	Respond to of 116759

GM cotton is not "medicated" unless one considers the tobacco genes.

To: E. Charters who wrote (81221)	4/9/2002 3:49:20 PM
From: long-gone	Read Replies (1) \| Respond to of 116759

OT Update While you & I have often disagreed about GM foods, it is time for you to try one. The Texas 1015 super sweet onion is in season! The 1015 onion has been genetically modified only by adding an extra sugar gene. Slice with a VERY sharp device to prevent excessive loss of juice. Here's a bit about it. agnews.tamu.edu valleygroves.com aggie-horticulture.tamu.edu

To: E. Charters who wrote (81221)	4/11/2002 5:00:36 PM
From: long-gone	Respond to of 116759

OT(perhaps not OT as this might stop population growth rate decline related deflation) Update GM foods Company Reports Edible AIDS Vaccine Milestone Wed Apr 10, 5:21 PM ET NEW YORK (Reuters Health) - A biotechnology company announced Tuesday that it has produced genetically modified corn that contains a protein found on the surface of HIV (news - web sites), the virus that causes AIDS (news - web sites). ProdiGene Inc. has been working with the National Institutes of Health (news - web sites) (NIH) to develop an edible AIDS vaccine, and the announcement represents a step toward this goal. In November 2000, ProdiGene announced that it had received a 2-year grant from the NIH to develop genetically enhanced corn that could serve as an oral delivery system for an AIDS vaccine. The company believes that this would allow global populations, especially those in developing nations that lack the healthcare infrastructure needed to administer traditional vaccines, to be vaccinated against AIDS safely and economically by consuming corn-based products such as cereal. As part of the effort, ProdiGene is also seeking to develop a source of SIV gp120, a protein found on the surface of both HIV and the monkey version of the pathogen, simian immunodeficiency virus (SIV), and a major component of most vaccines against the viruses. According to ProdiGene, it was able to express SIV gp120 in corn plants, creating a potential source of the protein for AIDS research. The company said its next step will be to begin animal studies to see if ingestion of the corn elicits an immune response. A spokesman for the privately held College Station, Texas-based company told Reuters Health that those animal studies are expected to begin this summer. He added that ProdiGene is currently engaged in discussions with the NIH about extending their alliance, as both partners have expressed interest in continuing the project. story.news.yahoo.com